Trial Result Confirms the Advantage of Cemiplimab for Skin Cancer at High Risk of Recurrence
We usually don’t feature nonmelanoma skin cancer articles here, but we thought you might be interested in what’s happening in…
Blog - Melanoma360
06/03/2025
Trial Result Confirms the Advantage of Cemiplimab for Skin Cancer at High Risk of Recurrence
We usually don’t feature nonmelanoma skin cancer articles here, but we thought you might be interested in what’s happening in…
|
05/28/2025
Halozyme Announces Bristol Myers Squibb Received European Commission Approval for Subcutaneous Opdivo® (nivolumab) Co-Formulated with ENHANZE® Across Multiple Solid Tumor Indications
News provided byHalozyme Therapeutics, Inc. May 28, 2025, 08:30 ET Opdivo® is the first and only PD-1 inhibitor approved for subcutaneous (SC)…
|
|
05/14/2025
Parenting Through Cancer
In this deeply personal episode, Drs. Samantha and Samuel Siegel share their journey of navigating cancer, medical school, and family…
|
05/09/2025
Tri-State Melanoma Consortium – Inaugural Convening
Last night, leading melanoma researchers and clinicians from across the New York , New Jersey, and Connecticut region gathered at…
|
05/01/2025
AIM at Melanoma + WEARSPF®: Partnering for a Cause This Melanoma Awareness Month
May is Melanoma Awareness Month—a time to come together, raise awareness, and take meaningful steps toward ending one of the…
|
05/01/2025
Hope, Purpose, and Progress: Melanoma Awareness Month with AIM
Dear Friend, May is Melanoma Awareness Month, a time to honor the progress made in the fight against this deadly…
|
04/28/2025
Your Style Can Save Lives – Lilly Pulitzer Giving Day is Here!
Mark your calendar—May 2nd is a day to shop for a cause! We’re thrilled to announce that AIM at Melanoma…
|
04/28/2025
From Diagnosis to Crown: Miss Pennsylvania’s Journey of Advocacy and Awareness
By Mara Klecker Page Weinstein has a special request for photographers who take her portraits: Don’t edit out the scar…
|
04/24/2025
Worried Your Immunotherapy Isn’t Working: The Role of Imaging and ctDNA
Introduction Immunotherapy drugs like ipilimumab (Yervoy), nivolumab (Opdivo), pembrolizumab (Keytruda), and others are powerful tools to combat melanoma. Indeed, recent…
04/24/2025
Genetic Testing Performed in Melanoma
A Q&A with an Investigator at the National Institutes of Health Dr. Michael Sargen M.D. is an Assistant Clinical Investigator…
|
Recent Posts
Jan. 13, 2026
The Integrative Care Approach
Jan. 13, 2026
Improved Response to Immunotherapy with COVID-19 mRNA Vaccines
Dec. 09, 2025
One Day at a Time: Caregiving Through Ocular Melanoma
Nov. 24, 2025
A Life Rewritten: Finding Strength in the Face of Melanoma
Nov. 20, 2025